当前位置： SCI文献检索 > Applied Health Economics and Health Policy期刊下所有文献 > Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules.

Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules.

Abstract：

:In Germany, the Institute for Quality and Efficiency in Health Care (IQWiG) makes recommendations for ceiling prices of drugs based on an evaluation of the relationship between costs and effectiveness. To set ceiling prices, IQWiG uses the following decision rule: the incremental cost-effectiveness ratio (ICER) of a new drug compared with the next effective intervention should not be higher than that of the next effective intervention compared with its comparator. The purpose of this article is to analyse ethical implications of IQWiG's rule and compare them with those of two alternative decision rules, one that is based on an absolute cost-effectiveness threshold and one that falls in between. To this end, constrained optimization problems are defined that yield each decision rule. This article shows that IQWiG's rule accounts for severity of disease and past resource consumption. Potential problems and pitfalls are discussed.

journal_name

Appl Health Econ Health Policy

journal_title

Applied health economics and health policy

authors

Gandjour A

doi

10.2165/11586640-000000000-00000

subject

Has Abstract

pub_date

2011-03-01 00:00:00

pages

65-71

issue

2

eissn

1175-5652

issn

1179-1896

pii

1

journal_volume

9

pub_type

杂志文章

相关文献

Applied Health Economics and Health Policy文献大全
  • Current and future economic burden of osteoporosis in New Zealand.

    abstract：BACKGROUND:Osteoporosis is recognized as a serious health condition in developed as well as developing countries. There are no accurate estimates of the extent of the burden of osteoporosis in New Zealand. The purpose of this study was to estimate the economic burden of osteoporosis in New Zealand using data from inter...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11531500-000000000-00000

    authors： Brown P,McNeill R,Leung W,Radwan E,Willingale J

    更新日期：2011-03-01 00:00:00

  • The influence of bonus payments to doctors on hospital revenue: results of a quasi-experimental study.

    abstract：:There is wide consensus that the ways in which providers are reimbursed by third parties will affect their behaviour and, hence, the efficient use of limited resources and the performance of health systems. However, there seems to be little evidence on how payment to hospital-based doctors affects hospital performance...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：

    authors： Liu X,Mills A

    更新日期：2003-01-01 00:00:00

  • The Cost and Outcome Effectiveness of Total Hip Replacement: Technique Choice and Volume-Output Effects Matter.

    abstract：BACKGROUND:Total hip replacement (THR) must be managed in a more sustainable manner. More cost-effective surgical techniques and the centralization/regionalization of services are two solutions. The former requires an assessment of newer minimally invasive and muscle-sparing surgical techniques. The latter necessitates...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-016-0260-3

    authors： Goldstein JP,Babikian GM,Rana AJ,Mackenzie JA,Millar A

    更新日期：2016-12-01 00:00:00

  • Virtual Touch™ Quantification to Diagnose and Monitor Liver Fibrosis in Hepatitis B and Hepatitis C: A NICE Medical Technology Guidance.

    abstract：:Virtual Touch™ Quantification (VTq) is a software application used with Siemens Acuson ultrasound scanners to assess the stiffness of liver tissue. The National Institute for Health and Care Excellence (NICE) Medical Technologies Advisory Committee (MTAC) selected VTq for evaluation and invited the company to submit c...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-016-0277-7

    authors： Summers JA,Radhakrishnan M,Morris E,Chalkidou A,Rua T,Patel A,McMillan V,Douiri A,Wang Y,Ayis S,Higgins J,Keevil S,Lewis C,Peacock J

    更新日期：2017-04-01 00:00:00

  • Health Insurance in Sub-Saharan Africa: A Scoping Review of the Methods Used to Evaluate its Impact.

    abstract：:We conducted a scoping review with the objective of synthesizing available literature and mapping what designs and methods have been used to evaluate health insurance reforms in sub-Saharan Africa. We systematically searched for scientific and grey literature in English and French published between 1980 and 2017 using...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-019-00499-y

    authors： Degroote S,Ridde V,De Allegri M

    更新日期：2020-12-01 00:00:00

  • Cost of Medicare for All: Review of the Estimates.

    abstract：:This paper critically evaluates the estimates of the cost of Medicare for All (M4A) in the USA. Six studies that estimate the 1-year total cost of M4A in the USA are reviewed. These studies find that M4A would increase national health spending by as much as 16.9% or decrease it by 20.0%, representing a range of estima...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-021-00636-6

    authors： Nyman JA

    更新日期：2021-01-25 00:00:00

  • Prescribing incentive schemes : a useful approach?

    abstract：INTRODUCTION:From 2000 to 2004, primary care organisations (PCOs) in England were legally required to operate a prescribing incentive scheme for their general practices. A statutory framework specified the types of target, maximum rewards and use of 'good cause for failure' provisions that schemes should include. Our o...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/00148365-200504020-00005

    authors： Mason AR,Drummond MF,Hunter JA,Towse AK,Cooke J

    更新日期：2005-01-01 00:00:00

  • Curos™ Disinfection Caps for the Prevention of Infection When Using Needleless Connectors: A NICE Medical Technologies Guidance.

    abstract：:Central line-associated bloodstream infections (CLABSIs) are primary, laboratory confirmed bloodstream infections in patients with a central line within 48 h of symptom onset. Catheter-related bloodstream infection (CRBSI) is a more specific term used when the cause of infection has been confirmed by catheter tip cult...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-020-00602-8

    authors： O'Connell S,Dale M,Morgan H,Carter K,Carolan-Rees G

    更新日期：2020-08-05 00:00:00

  • A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zea

    abstract：OBJECTIVES:Invasive pneumococcal disease (IPD), pneumonia and acute otitis media (AOM) still represent a significant medical burden in children < 5 years of age in New Zealand (NZ), with marked disparities across socio-economic and ethnic groups. This cost-effectiveness evaluation aims to compare the potential impact o...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-018-0387-5

    authors： Varghese L,Talbot L,Govender A,Zhang XH,Mungall BA

    更新日期：2018-06-01 00:00:00

  • A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators.

    abstract：:This article aims to define a value-based approach to pricing and reimbursement for off-patent originators using a multiple criteria decision analysis (MCDA) approach centered on a systematic analysis of current pricing and reimbursement policies in China. A drug price policy review was combined with a quantitative an...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-014-0150-5

    authors： Hu S,Zhang Y,He J,Du L,Xu M,Xie C,Peng Y,Wang L

    更新日期：2015-08-01 00:00:00

  • Economic analysis of thrombo inCode, a clinical-genetic function for assessing the risk of venous thromboembolism.

    abstract：BACKGROUND:Patients with venous thromboembolism (VTE) commonly have an underlying genetic predisposition. However, genetic tests nowadays in use have very low sensitivity for identifying subjects at risk of VTE. Thrombo inCode(®) is a new genetic tool that has demonstrated very good sensitivity, thanks to very good cov...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-015-0153-x

    authors： Rubio-Terrés C,Soria JM,Morange PE,Souto JC,Suchon P,Mateo J,Saut N,Rubio-Rodríguez D,Sala J,Gracia A,Pich S,Salas E

    更新日期：2015-04-01 00:00:00

  • The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand.

    abstract：BACKGROUND:Concerns about the long-term sustainability of health care expenditures (HCEs), particularly prescribing expenditures, has become an important policy issue in most developed countries. Previous studies suggest that proximity to death (PTD) has a significant effect on total HCEs, with its exclusion leading to...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-014-0121-x

    authors： Moore PV,Bennett K,Normand C

    更新日期：2014-12-01 00:00:00

  • Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.

    abstract：BACKGROUND:Cervical cancer ranks fourth amongst the commonest malignancies worldwide and the second most prevalent cancer afflicting women in low-to-middle income countries (LMICs), hence, of great public health importance. LMICs are the most affected regions as evidenced by their high prevalence of the disease. Mortal...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-020-00576-7

    authors： Okeah BO,Ridyard CH

    更新日期：2020-10-01 00:00:00

  • Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.

    abstract：BACKGROUND:Although the costs of treating inflammatory bowel disease (IBD) in developed countries are well established, they remain largely unknown in countries with recent histories of socio-economic transition including Serbia. OBJECTIVE:To estimate the costs of treatment including the resources used by patients wit...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-016-0272-z

    authors： Kostić M,Djakovic L,Šujić R,Godman B,Janković SM

    更新日期：2017-02-01 00:00:00

  • The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.

    abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cancer in Taiwan. For males in Taiwan, it is the most dangerous cancer, with both the highest incidence and mortality rate. OBJECTIVE:To determine cancer-related medical care costs for long-term survivors of HCC. METHODS:The estimation of the lifetim...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/00148365-200806010-00005

    authors： Lang HC,Wu JC,Yen SH,Lan CF,Wu SL

    更新日期：2008-01-01 00:00:00

  • Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.

    abstract：BACKGROUND:It is estimated that annually 300 000 cases of rotavirus-induced gastroenteritis (RVGE) occur in children aged up to 5 years in France. A two-dose vaccine against rotavirus infection (RIX4414; Rotarix, GlaxoSmithKline), has been shown to be highly effective against severe RVGE. OBJECTIVE:This study evaluate...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/BF03256134

    authors： Standaert B,Parez N,Tehard B,Colin X,Detournay B

    更新日期：2008-01-01 00:00:00

  • Explaining the health costs associated with managing intracranial aneurysms in Italy.

    abstract：BACKGROUND:The clinical management of intracranial aneurysms is debated in many countries because of the associated disability risk and costs. Therefore, estimating the costs and explaining their variability will provide important information for decision makers. OBJECTIVE:We aimed to evaluate the acute and post-acute...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-013-0041-1

    authors： Calciolari S,Torbica A,Tarricone R

    更新日期：2013-08-01 00:00:00

  • Modelling the costs and outcomes of changing rates of screening for alcohol misuse by GPs in the Australian context.

    abstract：AIM:To assess the relative cost effectiveness of four strategies (academic detailing, computerised reminder systems, target payments and interactive continuing medical education) to increase the provision of screening and brief interventions by Australian GPs with the ultimate goal of decreasing risky alcohol consumpti...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/00148365-200605030-00002

    authors： Shanahan M,Shakeshaft A,Mattick RP

    更新日期：2006-01-01 00:00:00

  • Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review.

    abstract：BACKGROUND:Low back pain (LBP) is a major health problem, having a substantial effect on peoples' quality of life and placing a significant economic burden on healthcare systems and, more broadly, societies. Many interventions to alleviate LBP are available but their cost effectiveness is unclear. OBJECTIVES:To identi...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-016-0268-8

    authors： Andronis L,Kinghorn P,Qiao S,Whitehurst DG,Durrell S,McLeod H

    更新日期：2017-04-01 00:00:00

  • Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.

    abstract：BACKGROUND:Response to growth hormone (GH) therapy may vary between individual patients. Therefore the use of GH in children should be closely monitored to avoid over, under, or ineffective treatment regimens. The treatment response can be evaluated using growth prediction models. In an effort to improve the accuracy o...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-013-0030-4

    authors： Kaspers S,Ranke MB,Han D,Loftus J,Wollmann H,Lindberg A,Roelants M,Kleintjens J

    更新日期：2013-06-01 00:00:00

  • Cost and Budget Impact Analysis of an Accurate Intraoperative Sentinel Lymph Node Diagnosis for Breast Cancer Metastasis.

    abstract：BACKGROUND:Conventional intraoperative sentinel lymph node biopsy (SLNB) in breast cancer (BC) has limitations in establishing a definitive diagnosis of metastasis intraoperatively, leading to an unnecessary second operation. The one-step nucleic amplification assay (OSNA) provides accurate intraoperative diagnosis and...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-016-0235-4

    authors： Saruta Y,Puig-Junoy J

    更新日期：2016-06-01 00:00:00

  • Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany.

    abstract：BACKGROUND:Treatment with antipsychotic medication is an important element of relapse prevention in the management of schizophrenia, and can reduce inpatient stays. Recently, the long-acting atypical antipsychotic paliperidone long-acting injectable (PLAI), a once-monthly LAI antipsychotic, was approved for treatment o...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-013-0050-0

    authors： Zeidler J,Mahlich J,Greiner W,Heres S

    更新日期：2013-10-01 00:00:00

  • The infrastructure of obesity and the obesity epidemic: implications for public policy.

    abstract：:If present increases in the rate of obesity persist, by 2015 half of the population in the US could be obese. This article presents the case that the reason for the epidemic is an 'infrastructure of obesity' that fuels the phenomenon. To control this epidemic, public policy in general and health policy in particular n...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/00148365-200504030-00001

    authors： Stanton KR,Acs ZJ

    更新日期：2005-01-01 00:00:00

  • Financial risk of the biotech industry versus the pharmaceutical industry.

    abstract：:The biotech industry now accounts for a substantial and growing proportion of total R&D spending on new medicines. However, compared with the pharmaceutical industry, the biotech industry is financially fragile. This article illustrates the financial fragility of the biotech and pharmaceutical industries in the US and...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/BF03256149

    authors： Golec J,Vernon JA

    更新日期：2009-01-01 00:00:00

  • Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review.

    abstract：OBJECTIVES:The aim of this review is to assess the current state of empirical research regarding the effectiveness of national pricing regulations of the patent-protected market for prescription pharmaceuticals. Effectiveness is understood to be the capacity of policies to have a desired impact on outcomes, such as hea...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-018-0437-z

    authors： Wettstein DJ,Boes S

    更新日期：2019-04-01 00:00:00

  • Economic evaluations of guideline-based or strategic interventions for the prevention or treatment of chronic wounds.

    abstract：BACKGROUND:Costs of chronic wound care are significant, but systematic reviews of cost-effectiveness studies regarding guideline-based or strategic interventions are scarce. OBJECTIVES:Our objectives were to assess/compare the cost effectiveness of new interventions/systems designed to improve the prevention/treatment...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-014-0094-9

    authors： Carter MJ

    更新日期：2014-08-01 00:00:00

  • The impact of inclusion criteria in health economic assessments.

    abstract：:The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic assessments based on c...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11590150-000000000-00000

    authors： Richter A,Thieda P,Thaler K,Gartlehner G

    更新日期：2011-05-01 00:00:00

  • Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.

    abstract：BACKGROUND:Canadian patients, healthcare providers and payers share interest in assessing the value of self-monitoring of blood glucose (SMBG) for individuals with type 2 diabetes but not on insulin. Using the UKPDS (UK Prospective Diabetes Study) model, the Canadian Optimal Prescribing and Utilization Service (COMPUS)...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11594270-000000000-00000

    authors： Tunis SL

    更新日期：2011-11-01 00:00:00

  • Genetic health technology and economic evaluation: a critical review.

    abstract：:The aim of the review is to establish whether, on the basis of previous published evidence, current accepted guidance for health economic evaluation needs to be adapted to evaluate healthcare based on use of genetic information. Online literature search strategies were designed (using PubMed and the NHS Economic Evalu...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.2165/00148365-200605010-00004

    authors： Jarrett J,Mugford M

    更新日期：2006-01-01 00:00:00

  • A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.

    abstract：BACKGROUND:As tuberculosis screening trends to targeting high-risk populations, knowing the cost effectiveness of such screening is vital to decision makers. OBJECTIVES:The purpose of this review was to compile cost-utility analyses evaluating latent tuberculosis infection (LTBI) screening in high-risk populations tha...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-015-0183-4

    authors： Campbell JR,Sasitharan T,Marra F

    更新日期：2015-08-01 00:00:00